关注
Boukje Dijkstra
Boukje Dijkstra
Researcher, lecturer, director NISPA (Nijmegen Institute for Scientist-Practitioners in Addiction)
在 ru.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders
PJ Carpentier, CAJ De Jong, BAG Dijkstra, CAG Verbrugge, PFM Krabbe
Addiction 100 (12), 1868-1874, 2005
1302005
Prevalence of cognitive impairment in patients with substance use disorder
CJWH Bruijnen, BAG Dijkstra, SJW Walvoort, W Markus, ...
Drug and alcohol review 38 (4), 435-442, 2019
1142019
Gamma-hydroxybutyrate detoxification by titration and tapering
CAJ de Jong, R Kamal, BAG Dijkstra, HA de Haan
European addiction research 18 (1), 40-45, 2011
622011
The neurobiological mechanisms of gamma-hydroxybutyrate dependence and withdrawal and their clinical relevance: a review
RM Kamal, MS van Noorden, E Franzek, BAG Dijkstra, AJM Loonen, ...
Neuropsychobiology 73 (2), 65-80, 2016
572016
Pharmacological treatment in γ-hydroxybutyrate (GHB) and γ-butyrolactone (GBL) dependence: detoxification and relapse prevention
RM Kamal, MS van Noorden, W Wannet, H Beurmanjer, BAG Dijkstra, ...
CNS drugs 31, 51-64, 2017
562017
Psychometric properties of the Montreal Cognitive Assessment (MoCA) in healthy participants aged 18–70
CJWH Bruijnen, BAG Dijkstra, SJW Walvoort, MJJ Budy, H Beurmanjer, ...
International Journal of Psychiatry in Clinical Practice 24 (3), 293-300, 2020
482020
CLINICAL STUDY: Does naltrexone affect craving in abstinent opioid‐dependent patients?
BAG Dijkstra, CAJ De Jong, SM Bluschke, PFM Krabbe, ...
Addiction Biology 12 (2), 176-182, 2007
422007
Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: the Dutch GHB monitor project
BAG Dijkstra, R Kamal, MS van Noorden, H de Haan, AJM Loonen, ...
Drug and Alcohol Dependence 170, 164-173, 2017
332017
Baclofen to prevent relapse in gamma-hydroxybutyrate (GHB)-dependent patients: a multicentre, open-label, non-randomized, controlled trial
H Beurmanjer, RM Kamal, CAJ de Jong, BAG Dijkstra, AFA Schellekens
CNS drugs 32, 437-442, 2018
272018
The Montreal Cognitive Assessment (MoCA) as a cognitive screen in addiction health care: a validation study for clinical practice
CJWH Bruijnen, M Jansen, BAG Dijkstra, SJW Walvoort, S Lugtmeijer, ...
Journal of Substance Use 24 (1), 47-54, 2019
232019
A case series of pharmaceutical gamma-hydroxybutyrate in 3 patients with severe benzodiazepine-resistant gamma-hydroxybutyrate withdrawal in the hospital
MS van Noorden, RM Kamal, BAG Dijkstra, R Mauritz, CAJ de Jong
Psychosomatics 56 (4), 404-409, 2015
232015
Psychometric evaluation of the Dutch version of the Subjective Opiate Withdrawal Scale (SOWS)
BAG Dijkstra, PFM Krabbe, TGM Riezebos, CPF Van der Staak, ...
European Addiction Research 13 (2), 81-88, 2007
222007
Prediction of abstinence in opioid-dependent patients
BAG Dijkstra, CAJ De Jong, PFM Krabbe, CPF van der Staak
Journal of Addiction Medicine 2 (4), 194-201, 2008
212008
Prediction of withdrawal symptoms during opioid detoxification
BAG Dijkstra, PFM Krabbe, CAJ De Jong, CPF van der Staak
Journal of Opioid Management 4 (5), 311-319, 2008
212008
Palliative care for patients with substance use disorder and multiple problems: a qualitative study on experiences of healthcare professionals, volunteers and experts-by-experience
A Ebenau, B Dijkstra, C Ter Huurne, J Hasselaar, K Vissers, M Groot
BMC palliative care 19 (1), 1-13, 2020
202020
Palliative care for people with substance use disorder and multiple problems: a qualitative study on experiences of patients and proxies
A Ebenau, B Dijkstra, C Ter Huurne, J Hasselaar, K Vissers, M Groot
BMC palliative care 18 (1), 1-12, 2019
202019
Good psychometric properties of the addiction version of the revised illness perception questionnaire for health care professionals
AP Ayu, B Dijkstra, M Golbach, C De Jong, A Schellekens
PloS one 11 (11), e0164262, 2016
192016
Clinical relevance of immersive virtual reality in the assessment and treatment of addictive disorders: a systematic review and future perspective
S Langener, J Van Der Nagel, J van Manen, W Markus, B Dijkstra, ...
Journal of clinical medicine 10 (16), 3658, 2021
182021
Unity in diversity: a systematic review on the GHB using population
BAG Dijkstra, H Beurmanjer, AE Goudriaan, AFA Schellekens, ...
International Journal of Drug Policy 94, 103230, 2021
182021
Baclofen as relapse prevention in the treatment of gamma-hydroxybutyrate (GHB) dependence: an open label study
RM Kamal, A Schellekens, CAJ De Jong, BAG Dijkstra
BMC psychiatry 15 (1), 1-8, 2015
182015
系统目前无法执行此操作,请稍后再试。
文章 1–20